March 12, 2019 Clinical Research/Diagn. M&A, Partnerships

Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

San Diego, Calif. and Wilmington, Mass. – March 12, 2019 – Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced a licensing agreement with Charles River Laboratories International, Inc.’s Research Models and Services business. The agreement, designed to expand access to... Read more

September 26, 2018 Bio/Pharma/CRO Cell Analysis Tools M&A, Partnerships

Nanion Technologies places two SyncroPatch 384PE Instruments for Ion Channel Screening at Charles River Laboratories

https://www.nanion.de/images/Downloads_pdf/Press_Releases/180926_PR_Charles_River.pdf   Livingston, N.J., Munich, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments will be delivered to Charles... Read more